Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00483249 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2026 to Dec 2027 Site contacts updated at 2 of 2 sitesv23 Show all 2 changesShow less
    • Site contacts updated at 2 of 2 sites
  2. Lead sponsor: Timothy Chuter, MD to Warren J. Gasper, MD Site contacts updated at 2 of 2 sitesv22 Show all 2 changesShow less
    • Site contacts updated at 2 of 2 sites
  3. Re-verified, no change to tracked fieldsv21
  4. Site contacts updated at 2 of 2 sitesv20
  5. Primary completion date: Dec 2021 to Dec 2026 Completion date: Jun 2022 to Dec 2026v19 Show all 2 changesShow less
    • Completion date: Jun 2022 to Dec 2026
Show 17 earlier versionsHide 17 earlier versions
  1. Lead sponsor: University of California, San Francisco to Timothy Chuter, MD Primary completion date: Dec 2020 to Dec 2021 · Completion date: Dec 2020 to Jun 2022v18 Show all 3 changesShow less
    • Primary completion date: Dec 2020 to Dec 2021
    • Completion date: Dec 2020 to Jun 2022
  2. Phase: Phase 1/2 to Not applicablev17
  3. Re-verified, no change to tracked fieldsv16
  4. Enrollment target: 200 to 250 Completion date: Dec 2020v15 Show all 2 changesShow less
    • Completion date: Dec 2020
  5. Publications: 30 to 31v14 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  6. Site contacts updated at 2 of 2 sites Publications: 29 to 30v13 Show all 2 changesShow less
    • Publications: 29 to 30

    See this version in full on ClinicalTrials.gov ↗

  7. Primary completion date: Dec 2018 to Dec 2020v12
  8. Enrollment target: 140 to 200 Site contacts updated at 2 of 2 sites · Publications: 22 to 29v11 Show all 3 changesShow less
    • Site contacts updated at 2 of 2 sites
    • Publications: 22 to 29

    See this version in full on ClinicalTrials.gov ↗

  9. Site contacts updated at 1 of 2 sites Study arms: 0 to 1v10 Show all 2 changesShow less
    • Study arms: 0 to 1
  10. Primary completion date: Dec 2014 to Dec 2018v9
  11. Enrollment target: 120 to 140 Eligibility criteria expanded, about 10 wordsv8 Show all 2 changesShow less
    • Eligibility criteria expanded, about 10 words

    See this version in full on ClinicalTrials.gov ↗

  12. Enrollment target: 55 to 120 Site contacts updated at 2 of 2 sitesv7 Show all 2 changesShow less
    • Site contacts updated at 2 of 2 sites
  13. Primary completion date: Jan 2009 to Dec 2014v6
  14. 2 versions Re-verified since Jun 9, 2008, no change to tracked fieldsv4-v5
  15. Primary completion date: Jan 2009v3
  16. Publications: 11 to 22v2 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
Trial Details
NCT Number NCT00483249
Lead Sponsor Warren J. Gasper, MD
Conditions Thoracoabdominal Aortic Aneurysm, Paravisceral Abdominal Aortic Aneurysm
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov